We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+4.29%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$41.2B
AUM Growth
+$785M
(+1.9%)
Cap. Flow
-$197M
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
16.49%
Holding
2,297
New
154
Increased
708
Reduced
1,158
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$171M |
| 2 |
Regions Financial
RF
|
+$151M |
| 3 |
Alibaba
BABA
|
+$109M |
| 4 |
Coca-Cola
KO
|
+$75.9M |
| 5 |
Amcor
AMCR
|
+$67.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Electric Power
AEP
|
+$183M |
| 2 |
Procter & Gamble
PG
|
+$154M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$138M |
| 4 |
Crown Castle
CCI
|
+$135M |
| 5 |
Baidu
BIDU
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.02% |
| 2 | Technology | 14.7% |
| 3 | Financials | 10.86% |
| 4 | Consumer Staples | 10.23% |
| 5 | Consumer Discretionary | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
776
DELISTED
Rubius Therapeutics, Inc
RUBY
| $5.11M | 0.01% |
325,000
+78,070
| +32% | +$1.26M |
|
|
VRNT
777
DELISTED
Verint Systems
VRNT
| $5.08M | 0.01% |
185,513
+110,536
| +147% | +$3.32M |
|
778
OGE Energy
OGE
$9.78B
| $5.03M | 0.01% |
118,210
+6,395
| +6% | +$271K |
|
|
CVSA
779
Covista Inc
CVSA
$4.25B
| $5M | 0.01% |
110,953
-17,716
| -14% | -$813K |
|
780
STMicroelectronics
STM
$46.7B
| $4.99M | 0.01% |
283,050
-5,961
| -2% | -$101K |
|
781
Virtu Financial
VIRT
$5.11B
| $4.97M | 0.01% |
228,298
-19,680
| -8% | -$463K |
|
782
Supernus Pharmaceuticals
SUPN
$2.59B
| $4.96M | 0.01% |
149,732
+119,974
| +403% | +$4.11M |
|
783
First Commonwealth Financial
FCF
$2.18B
| $4.95M | 0.01% |
367,724
+67,135
| +22% | +$886K |
|
784
Dana Inc
DAN
$2.9B
| $4.93M | 0.01% |
247,384
-17,632
| -7% | -$314K |
|
|
CPE
785
DELISTED
Callon Petroleum Company
CPE
| $4.92M | 0.01% |
74,617
-20,858
| -22% | -$1.5M |
|
|
ACIA
786
DELISTED
Acacia Communications Inc
ACIA
| $4.89M | 0.01% |
103,750
+72,128
| +228% | +$3.79M |
|
|
TPH
787
DELISTED
Tri Pointe Homes
TPH
| $4.89M | 0.01% |
408,548
-139,940
| -26% | -$1.82M |
|
788
Chemours
CC
$2.5B
| $4.88M | 0.01% |
203,154
-97,461
| -32% | -$2.87M |
|
789
ATI
ATI
$25.6B
| $4.86M | 0.01% |
192,774
-691,018
| -78% | -$16.8M |
|
|
SILK
790
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $4.85M | 0.01% |
+100,000
| New | +$4.25M |
|
791
Fate Therapeutics
FATE
$286M
| $4.82M | 0.01% |
237,317
-221,552
| -48% | -$3.99M |
|
792
Skywest
SKYW
$4.24B
| $4.81M | 0.01% |
79,301
+74,623
| +1,595% | +$4.42M |
|
793
ACI Worldwide
ACIW
$5.83B
| $4.81M | 0.01% |
139,932
+74,415
| +114% | +$2.47M |
|
794
OSI Systems
OSIS
$3.65B
| $4.8M | 0.01% |
+42,642
| New | +$4.3M |
|
|
MAXR
795
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $4.79M | 0.01% |
613,060
+309,624
| +102% | +$1.92M |
|
|
XEC
796
DELISTED
CIMAREX ENERGY CO
XEC
| $4.75M | 0.01% |
80,006
-66,821
| -46% | -$4.27M |
|
797
Artisan Partners
APAM
$2.79B
| $4.74M | 0.01% |
172,149
| – | – |
|
|
EEX
798
DELISTED
Emerald Holding
EEX
| $4.74M | 0.01% |
424,944
+24,830
| +6% | +$310K |
|
799
Regeneron Pharmaceuticals
REGN
$78.5B
| $4.73M | 0.01% |
15,119
-16,889
| -53% | -$5.62M |
|
|
AEL
800
DELISTED
American Equity Investment Life Holding Company
AEL
| $4.71M | 0.01% |
173,490
-54,100
| -24% | -$1.55M |
|
Similar funds
Federated Hermes's Q2 2019 Portfolio in Review
As of Q2 2019, Federated Hermes held 2,297 positions worth $41.2B, up 1.9% from $40.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2019 filing shows 154 new, 708 increased, 1,158 reduced and 139 closed positions. Its largest new stake was Amcor: 1,210,171 shares worth $69.5M. The largest sale was American Electric Power, an estimated $183M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2019 buy was Amcor: 1,210,171 shares worth $69.5M.
- Federated Hermes added most to Pfizer in Q2 2019, an estimated $171M increase.
- Federated Hermes's biggest Q2 2019 reduction was American Electric Power, cutting an estimated $183M.
- Federated Hermes fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
- Federated Hermes's ten largest holdings make up 16% of its $41.2B portfolio in Q2 2019.
- Federated Hermes opened 154 new positions and closed 139 in Q2 2019.
- Federated Hermes's portfolio value rose 1.9% quarter-over-quarter to $41.2B.
Based on Federated Hermes's 13F filing for Q2 2019, filed 14 Aug 2019.